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Ibuprofen and other 2-arylpropanoic acids (2-APAs) are non-steroidal anti-inflammatory 
drugs (NSAIDs) and the 2S- enantiomers act by inhibition of cyclo-oxygenase 1 and 2 (COX-
1 and -2). 2-APA drugs are given as racemic mixtures and chiral inversion is essential for 
pharmacological activity. This pathway for 2R-ibuprofen consists of conversion to the 2R-
acyl-CoA ester, chiral inversion to the 2S-epimer, and hydrolysis to 2S-ibuprofen. The chiral 
inversion reaction is catalysed by α-methylacyl-CoA racemase (AMACR; P504S). AMACR is 
increased ~10-fold in prostate and other cancers, and is a novel cancer drug target. Other 2-
APAs undergo chiral inversion in vivo, but it is unclear if AMACR is involved. 
The present study investigates whether AMACR catalyses chiral inversion of other 2-APA-
CoA esters. Substrates were incubated with human AMACR 1A in 2H2O-containing buffer 
and all exchanged the 2-proton, an obligatory step for chiral inversion. Derivatization of 
products from chiral substrates showed a ca. 1:1 epimeric mixture of products, consistent 
with the proposed deprotonation/reprotonation mechanism. Steady state kinetic analysis 
showed that most substrates were converted with similar efficiency (kcat/Km = 100-150 M-1 s-
1). Fenoprofenoyl-CoA was converted much more efficiently (kcat/Km = ~1426 M-1 s-1), due to 
its low Km value (~2.3 μM cf. 26-74 μM). 
The results suggest that all 2-APA drugs undergo the same chiral inversion pathway. 2-
APAs may be useful for treatment of cancers with increased AMACR levels. 
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